Evonik supports the advancement of polymeric nanoparticles through integrated process development and scale-up services. Evonik leverages its continuous nanoparticle manufacturing technologies to develop efficient, scalable production processes and can transition customer processes onto Evonik’s proprietary platform. These programs reduce development risk, support reliable supply for GLP toxicology/stability studies, and establish a robust foundation for clinical and commercial manufacturing.
Benefits at a glance
Experience
50+ years of process expertise and drug delivery innovation, supporting pharmaceutical development from concept through commercialization.
Innovative
Scalable continuous nanoparticle production technology designed to accelerate development and manufacturing.
Safe
Biocompatible, bioabsorbable RESOMER® and LACTEL® polymers with well-established safety profiles.
Trusted
Lactide/glycolide polymer technologies used in more than 60 approved pharmaceutical products worldwide